Peter Hesseling

4.6k total citations
100 papers, 1.9k citations indexed

About

Peter Hesseling is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Peter Hesseling has authored 100 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Public Health, Environmental and Occupational Health, 32 papers in Pediatrics, Perinatology and Child Health and 28 papers in Oncology. Recurrent topics in Peter Hesseling's work include Acute Lymphoblastic Leukemia research (35 papers), Childhood Cancer Survivors' Quality of Life (31 papers) and Lymphoma Diagnosis and Treatment (24 papers). Peter Hesseling is often cited by papers focused on Acute Lymphoblastic Leukemia research (35 papers), Childhood Cancer Survivors' Quality of Life (31 papers) and Lymphoma Diagnosis and Treatment (24 papers). Peter Hesseling collaborates with scholars based in South Africa, Cameroon and Netherlands. Peter Hesseling's co-authors include Elizabeth Molyneux, G. Wessels, Trijn Israëls, Robin Broadhead, Francine Kouya, Glenn Mbah Afungchwi, Nulda Beyers, Eric Borgstein, Lorna Renner and Robert P. Gie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Peter Hesseling

100 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hesseling South Africa 25 732 713 575 387 283 100 1.9k
Giuseppe Loverro Italy 33 723 1.0× 930 1.3× 290 0.5× 159 0.4× 531 1.9× 184 3.8k
Inge M. van der Sluis Netherlands 29 1.3k 1.8× 1.4k 2.0× 524 0.9× 236 0.6× 398 1.4× 104 3.2k
Maurizio Clementi Italy 35 634 0.9× 834 1.2× 165 0.3× 230 0.6× 496 1.8× 94 3.6k
H. Ekert Australia 23 473 0.6× 572 0.8× 248 0.4× 206 0.5× 239 0.8× 136 2.3k
Jerry Stein Israel 27 318 0.4× 332 0.5× 298 0.5× 89 0.2× 460 1.6× 119 2.3k
Roksana Karim United States 32 161 0.2× 366 0.5× 384 0.7× 385 1.0× 126 0.4× 84 2.7k
Stuart Gold United States 24 420 0.6× 558 0.8× 433 0.8× 106 0.3× 238 0.8× 53 1.8k
Reshef Tal United States 29 716 1.0× 1.3k 1.8× 126 0.2× 131 0.3× 341 1.2× 76 3.1k
Anders Kreuger Sweden 24 999 1.4× 465 0.7× 236 0.4× 109 0.3× 219 0.8× 65 1.9k
Orna Diav‐Citrin Israel 30 836 1.1× 2.0k 2.8× 105 0.2× 153 0.4× 129 0.5× 67 3.3k

Countries citing papers authored by Peter Hesseling

Since Specialization
Citations

This map shows the geographic impact of Peter Hesseling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hesseling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hesseling more than expected).

Fields of papers citing papers by Peter Hesseling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hesseling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hesseling. The network helps show where Peter Hesseling may publish in the future.

Co-authorship network of co-authors of Peter Hesseling

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hesseling. A scholar is included among the top collaborators of Peter Hesseling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hesseling. Peter Hesseling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hesseling, Peter, et al.. (2024). Burkitt lymphoma: The effect of age, sex and delay to diagnosis on treatment completion and outcome of treatment in 934 Patients in Cameroon. PLoS ONE. 19(3). e0299777–e0299777. 1 indexed citations
2.
Afungchwi, Glenn Mbah, et al.. (2019). Burkitt lymphoma: Trends in children below 15 years reveal priority areas for early diagnosis activities in north-west Cameroon. SHILAP Revista de lepidopterología. 3. 2 indexed citations
3.
Hesseling, Peter, et al.. (2019). Wilms tumour: Long-term survival of patients treated at Mbingo Baptist Hospital in Cameroon between 2007 and 2012. SHILAP Revista de lepidopterología. 3. 1 indexed citations
5.
Lesscher, Heidi M. B., et al.. (2015). Early social isolation augments alcohol consumption in rats. Behavioural Pharmacology. 26(7). 673–680. 41 indexed citations
6.
Koot, Susanne, et al.. (2014). Corticosterone and decision-making in male Wistar rats: the effect of corticosterone application in the infralimbic and orbitofrontal cortex. Frontiers in Behavioral Neuroscience. 8. 127–127. 18 indexed citations
7.
Israëls, Trijn, Claude Moreira, Sam Kampondeni, et al.. (2012). SIOP PODC: Clinical guidelines for the management of children with Wilms tumour in a low income setting. Pediatric Blood & Cancer. 60(1). 5–11. 74 indexed citations
8.
Michelow, Pamela, Gladwyn Leiman, Janet Poole, et al.. (2011). An interinstitutional review of the value of FNAB in pediatric oncology in resource‐limited countries. Diagnostic Cytopathology. 40(9). 770–776. 14 indexed citations
9.
Marjerrison, Stacey, et al.. (2011). The use of ultrasound in endemic Burkitt lymphoma in Cameroon. Pediatric Blood & Cancer. 58(3). 352–355. 12 indexed citations
10.
Israëls, Trijn, Marianne D. van de Wetering, Peter Hesseling, et al.. (2009). Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatric Blood & Cancer. 53(1). 47–52. 79 indexed citations
11.
Hesseling, Peter, Elizabeth Molyneux, Steve Kamiza, & Robin Broadhead. (2008). Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma. Transactions of the Royal Society of Tropical Medicine and Hygiene. 102(6). 602–607. 22 indexed citations
12.
Sinfield, Rebecca, Elizabeth Molyneux, Kondwani Joseph Banda, et al.. (2006). Spectrum and presentation of pediatric malignancies in the HIV era: Experience from Blantyre, Malawi, 1998–2003. Pediatric Blood & Cancer. 48(5). 515–520. 79 indexed citations
13.
Visser, J.H., et al.. (2001). PROGNOSTIC VALUE OF DAY 14 BLAST PERCENTAGE AND THE ABSOLUTE BLAST INDEX IN BONE MARROW OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Hematology and Oncology. 18(3). 187–191. 12 indexed citations
14.
Hesseling, Peter, et al.. (2000). High-dose intense chemotherapy in South African children with B-cell lymphoma: Morbidity, supportive measures, and outcome. Medical and Pediatric Oncology. 34(2). 143–143. 1 indexed citations
15.
Hesseling, Peter. (2000). The SIOP Burkitt lymphoma pilot study in Malawi, Africa. Medical and Pediatric Oncology. 34(2). 142–142. 4 indexed citations
16.
Hesseling, Peter, et al.. (1998). Bone mineral density in long‐term survivors of childhood cancer. International Journal of Cancer. 78(S11). 44–47. 3 indexed citations
17.
Wessels, G. & Peter Hesseling. (1996). Outcome of children treated for cancer in the republic of Namibia. Medical and Pediatric Oncology. 27(3). 160–164. 15 indexed citations
18.
Hesseling, Peter, G. Wessels, R. Maarten Egeler, & D. J. Rossouw. (1995). Simultaneous Occurrence of Viral-Associated Hemophagocytic Syndrome and Langerhans Cell Histiocytosis: A Case Report. Pediatric Hematology and Oncology. 12(2). 135–141. 20 indexed citations
19.
Cohn, Richard J., et al.. (1993). α‐interferon therapy for severe chronic idiopathic thrombocytopenic purpura in children. American Journal of Hematology. 43(4). 246–250. 10 indexed citations
20.
Wood, Robert E., C.J. Nortjé, Peter Hesseling, & F.W. Grotepass. (1990). Ewing's tumor of the jaw. Oral Surgery Oral Medicine Oral Pathology. 69(1). 120–127. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026